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~,bstract Neutrophil apoptosis represents a major mechanism 
~nvolved in the resolution of inflammation. Since hypoxia induces 
apoptosis in several cell lines and is of particular relevance in 
many disease states, we studied the effect of oxygen concentra- 
tion on neutrophil survival in vitro. Hypoxia caused a dramatic 
decrease in neutrophil apoptosis (% apoptosis 20 h: 78.7 + 2.2% 
in 21% 0 2, 61.4 _+ 6.5% in 2.5% 02, 23.1 + 3.2% in 0% 02, 
= 5). This was additive to the effect of GM-CSF (50 Ulml), not 
associated with induction of bcl-2 expression, and was not mim- 
icked by methionine (5 raM), superoxide dismutase (200 pg/ml) 
or Trolox (10 mM) but was mimicked by catalase (250/zg/ml). 
Hence, hypoxia has a bcl-2-independent effect on neutrophil ap- 
optosis that may adversely affect the clearance of these cells from 
an inflammatory focus. 
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1. Introduction 
During a bacterial invasion the body mounts an immune 
response involving recruitment of inflammatory cells into the 
area of infection [1]. One of the principal cells involved in this 
response is the neutrophil, which, when stimulated by a patho- 
gen, degranulates and undergoes respiratory burst activity, to 
release a variety of histotoxic enzymes and short-lived reactive 
oxygen species (ROS) [2]. Many of the antiproteinases that 
protect he host against neutrophil-mediated injury [3] are inac- 
tivated by oxidation, and hence local oxidant-antioxidant bal- 
ance appears to be a critical factor determining the extent of 
tissue damage [4]. The many deleterious contents of neutrophils 
necessitate hat for complete resolution of inflammation these 
cells should be removed in a way that limits cell activation, and 
neutrophil apoptosis represents an important mechanism 
wherby this may be achieved [5,6,7]. 
When neutrophils die by apoptosis they retain their granule 
contents but lose chemotactic and secretory responsiveness [8]
and thereafter are recognised and phagocytosed intact by mac- 
rophages [9] which fail to release pro-inflammatory mediators 
in response to this interaction [10]. Although neutrophils un- 
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dergo constitutive apoptosis in vitro [11], their survival may be 
increased by the addition of certain cytokines uch as granulo- 
cyte-macrophage colony-stimulating factor (GM-CSF) and 
bacterial products such as lipopolysaccharide (LPS) [12,13]. 
However, the intracellular signalling pathways that regulate 
neutrophil survival are unclear. 
Studies on the nematode, C. elegans, have shown that indi- 
vidual cell survival is signalled by the gene, ced-9 [14]. The 
mammalian homologue of the Ced-9 protein is Bcl-2 [l 5], which 
is capable of causing survival of a number of cell-lines and 
B-lymphocytes [16,17], an effect potentially mediated by the 
ability of Bcl-2 to inhibit oxidant-mediated cell damage [18,19]. 
This hypothesis arose from studies in which oxidant reatment 
of FL5.12 cells, an IL-3 dependent pro-B lymphocyte cell-line, 
caused an increase in apoptosis that could be counteracted by 
over-expression f bcl-2 [18], and studies in GT 1-7 neural cells 
where bcl-2 expression prevented eath induced by glutathione 
depletion [19]. Bcl-2 did not prevent free radical production but 
did appear to block the damaging effects of these agents. In 
contrast, Jacobson and Raft [20], and Shimizu et al. [21], have 
shown that the protective ffects of Bcl-2 are observed even 
under extreme hypoxic onditions where the generation of ROS 
is negligible. These latter studies also demonstrate hat hypoxia 
alone can induce apoptosis in certain cells [20,21]. 
To date, all the studies examining the potential involvement 
of reactive oxygen intermediates in regulating apoptosis have 
been undertaken in cell lines to allow manipulation of bcl-2 
levels. This is the first report to examine the effects of hypoxia 
on apoptosis in the neutrophil, a terminally differentiated cell 
that lacks detectable Bcl-2 [22]. In contrast to the above studies, 
we demonstrate a profound inhibition of neutrophil apoptosis 
by hypoxia. This effect of hypoxia on neutrophils may be of 
considerable r levance to conditions in vivo where the oxidant 
potential at sites of inflammatory disease may be extremely ow 
[23,24]. 
2. Materials and methods 
2.1. Materials" 
Unless otherwise stated, all chemicals and enzymes were purchased 
from Sigma (Dorset, UK), and all antibodies obtained from Dako 
(Bucks., UK). The plasticware was supplied by Becton Dickinson 
(Leics., UK) or Nunc (Paisley, UK), and the culture media were ob- 
tained from Life Technologies (Paisley, UK). Percoll and dextran were 
purchased from Pharmacia (Milton Keynes, UK), and GM-CSF (spe- 
cific activity 1.25 x 107 U/mg) from Genzyme Diagnostics (Kent, UK). 
Trolox (6-hydroxy-2,3,7,8-tetramethylchroman-2-carboxylic cid) was 
obtained from Aldrich (Dorset, UK). 
2.2. Isolation of neutrophils 
Peripheral venous blood was collected from healthy volunteers and 
placed in citrated polypropylene tubes (0.38% (v/v) final concentration 
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of sodium citrate solution). The whole blood was centrifuged (300 x g) 
for 20 min and the plasma removed. The leukocyte-rich fraction was 
separated from the erythrocytes in the remaining portion by dextran 
sedimentation [25]. Neutrophils in the leukocyte-rich fraction were sep- 
arated from mononuclear cells using a discontinuous plasma/Percoll 
gradient and collected from the 42%/51% plasma/Percoll interface. The 
isolated neutrophils were > 95% pure (< 0.1% mononuclear cells) and 
> 99% viable as determined by Trypan-blue dye exclusion. Previous 
studies have demonstrated that neutrophils i olated by this method are 
non-activated since they display <5% basal shape change, minimal 
basal superoxide or lysozyme generation and, unlike cells prepared 
using Ficoll-Hypaque gradients, exhibit normal chemotactic responses 
to N-formyl-methionyl-leucyl-phenylalanine (fMLP) [25]. 
2.3. Neutrophil culture 
Freshly harvested neutrophils were suspended ata density of 5 x 106/ 
ml in Iscove's DMEM supplemented with 10% autologous serum, pen- 
icillin (100 U/ml) and streptomycin (100 ~g/ml). Neutrophils 
(6.75 x 105) were cultured in a final volume of 150/~1 in flat-bottomed 
96-well polypropylene fl xiwell inserts. The plates were placed in sealed 
air-tight plastic boxes that were flushed through for 15 min with gas 
mixtures containing either 2.5% O215% CO2 or 21% O215% CO2 (con- 
trol), with the balance made up with nitrogen. The boxes were then 
incubated at 37°C for the time periods indicated. More extreme hypoxic 
conditions were achieved by placing cultured neutrophils in an MK3 
anaerobic incubator (0% 02, Don Whitley Scientific Ltd., Yorkshire, 
UK) fitted with a palladium catalyst. The level and stability of pO2 
achieved using the 2.5% 02 mixture was measured using a blood-gas 
analyser (model ABL-330 Radiometer, Copenhagen, Denmark). The 
pO2 values obtained were 8.69 + 0.73 kPa, 8.6 + 0.32 kPa and 
9.55 + 1.66 kPa after 0, 6 and 20 h, respectively, in culture in 2.5% Oz. 
Equilibrium of the pO2 and pCO2 in the medium took less than 30 rain 
with the boxes (2.5% 02) and less than 1 h with the anaerobic incubator 
(0% 02). To assess whether the effects of hypoxia influenced the known 
ability of GM-CSF to prolong neutrophil survival, cells were also incu- 
bated under hypoxic or normoxic onditions in the presence of absence 
of GM-CSF (50U/ml). 
2.4. Morphological assessment of apoptosis 
At the stated time points, neutrophils were gently resuspended, har- 
vested and cytocentrifuged. The resulting slides were fixed and stained 
with Diff-Quick. Cell recovery and viability by Trypan-blue dye exclu- 
sion were measured in parallel. Cell morphology was examined under 
a 100 x objective and apoptotic ells defined as cells containing darkly 
stained pyknotic nuclei [26]. Triplicate slides were prepared for each 
condition and at least 500 neutrophils counted per slide in random 
fields. 
2.5. Treatment with oxidants and antioxidants 
Freshly isolated neutrophils were suspended ata density of 5 x 106/ml 
in Iscove's DMEM supplemented with 10% autologous serum, penicil- 
lin (100 U/ml) and streptomycin (100/tg/ml) and dispensed into flat- 
bottomed 96-well polypropylene fl xiwell inserts. The neutrophils were 
treated with 200/tg/ml bovine erythrocyte SOD (750 U/ml), 250/,tg/ml 
bovine liver catalase (4750 U/ml), 200 ~g/ml SOD and 250 ,ug/ml eata- 
lase or 5 mM methionine. Control, untreated cells were also prepared. 
The cells were cultured for 6 or 20 h at 37°C under normoxic (5% 
CO2:air) conditions, after which cytocentrifuge preparations were made 
and apoptosis assessed morphologically. 
Assessment of the effect of hydrogen peroxide on the rate of neutro- 
phil apoptosis was studied by treating freshly isolated neutrophils 
(1 x 106/ml of Iscove's DMEM supplemented with 2% autologous 
serum, 100 U/ml penicillin and 100/,tg/ml streptomycin) with hydrogen 
peroxide (0.1 5 mM) in the presence or absence of the soluble vitamin 
E analogue 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 
(Trolox, l0 mM). Control, untreated cells, and cells treated with antiox- 
idant alone were also examined. The cells were cultured for 8 h at 37°C 
under normoxic (5% CO2:air) conditions, after which cytocentrifuge 
preparations were made and apoptosis assessed morphologically. 
2.6. Immunocytochemistry 
Cultured cells (1 × 105) were transferred into round-bottomed 96-well 
polypropylene, flexiwell inserts. The cells were simultaneously fixed and 
permeabilised with 50 ,ul 0.01% (w/v) L-c~-lysophosphatidylcholine in 
PBS containing 3.7% (v/v) formaldehyde for 15 rain at 37°C [27], The 
cells were then washed with PBS containing 0.5% (w/v) BSA and incu- 
bated (4°C) for 1 h with a saturating concentration f a mouse mono- 
clonal antibody raised against human Bcl-2 protein. As a positive con- 
trol, parallel samples were stained with MAC 387, a mouse monoclonal 
antibody which recognises p8,14, an intracellular calcium binding pro- 
tein complex found in neutrophils. The amount of primary antibody 
binding was detected using a FITC-conjugated goat anti-mouse poly- 
clonal antibody. Negative control cells were stained with second layer 
antibody alone. The samples were analysed using an EPICS profile II 
(Coulter Electronics, Luton, UK). 
2. Z Statistics 
All data are presented as mean + S.E.M. for (n) separate xperi- 
ments. Values were compared using the Student's t-test for paired data 
with P < 0.05 considered to be significant. 
3. Results and discussion 
Incubation of neutrophils under hypoxic conditions resulted 
in a dramatic inhibition ofapoptosis (Fig. la) to the extent hat 
cells incubated for 44 h in 0% 02 were >95% viable and <25% 
apoptotic ompared to nearly 100% apoptosis/necrosis under 
normoxic (21% O2) conditions (Fig. l b). These findings are in 
complete contrast to those of Jacobson and Raft  [20] and 
Shimizu et al. [21] who have shown that hypoxia induces apop- 
tosis in SV-40 transformed human fibroblasts (that lacked mi- 
tochondria) and a rat pheochromacytoma cell line, respectively. 
A similar induction of apoptosis by hypoxia has been reported 
in WEHI  7.1 T-lymphoma cells [28], adenocarcinoma HT29 
cells [29] and superior cervical ganglia cells [30]. In the studies 
of Jacobson and Raft  [20] and Shimizu et al. [21], apoptosis 
could be inhibited under both normoxic and hypoxic conditions 
by transfected bcl-2. Since we were unable to detect any Bcl-2 
protein in neutrophils aged under either hypoxic or normoxic 
conditions (Table 1), it is unlikely that the enhanced survival 
of neutrophils under hypoxic conditions was bcl-2-mediated. 
We have previously demonstrated that cytokine growth fac- 
tors such as GM-CSF are capable of extending the life of the 
neutrophil [31], and hence we investigated whether the effects 
of GM-CSF and hypoxia were mediated by a common mecha- 
nism. In fact, GM-CSF-  and hypoxia-mediated survival ofneu- 
trophils were additive (Fig. 2), suggesting that the hypoxia and 
GM-CSF effects are independent. 
To examine whether the effect of hypoxia was mediated by 
inhibition of ROS generation, we investigated whether ex- 
ogenous addition of antioxidant enzymes and methionine, an 
essential thiol containing amino acid, would mimic the hypoxic 
Table 1 
Effect of hypoxic culture on Bcl-2 in neutrophils 
% oxygen Amount of detectable Bcl-2 (Relative Mean Fluorescence) 
-GMCSF +GMCSF 
0% 1.14 + 0.14 1.01 + 0.24 
21% 1.09 _+ 0.12 1.01 + 0.014 
Neutrophils were incubated in the presence or absence of GMCSF (50 
U/ml) for 20 h in atmospheres containing 0% or 21% O2. The amount 
of Bcl-2 in the cells was measured as detailed in section 2 and expressed 
as mean fluorescence relative to negative control. In all cases, Bcl-2 
could not be detected in the neutrophils. HL60 cells, which are known 
to express Bcl-2, were used as a positive control (relative mean fluores- 
cence = 4.43). MAC 387, which recognises an intracellular antigen in 
neutrophils, was used confirm the efficient permeabilisation f the 
neutrophils (relative mean fluorescence > 50). 
;. Hannah et al . /FEBS Letters 372 (1995) 233-237 235 
effect. These agents had no effect on cell viability after 20 h of 
culture as measured by Trypan-blue xclusion which supports 
:t previous study [32]. Methionine and SOD did not influence 
'.he rate of neutrophil apoptosis (Fig. 3) suggesting that hy- 
)ochlorous and superoxide radicals do not play a significant 
ole in regulating neutrophil apoptosis. This supports a previ- 
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Fig. 1. Effect of hypoxia on neutrophil apoptosis. Neutrophils were 
incubated in atmospheres containing either 21%, 2.5% or 0% 02 for 6 
hrs (open bars) or 20 hrs (closed bars) in (a) or 21% (closed symbols) 
and 0% (open symbols) in (b). The percentage apoptosis was assessed 
morphologically asdetailed in section 2 at the time points indicated. 
Data in (a) represent mean +_ S.E.M. of n = 5 separate xperiments, 
each performed in triplicate. In (b), culture of cells for 44 h in the 
presence of 21% 02 caused amajor increase in the percentage necrotic 
cells (as assessed by Trypan-blue dye exclusion) and therefore itwas not 
possible to determine the percentage of apoptotic ells at this time 
point. The data in (b) represent mean + S.E.M. of triplicate incubations 
from a single representative experiment. 
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Fig. 2. Modulation of the GMCSF survival effect in neutrophils by 
hypoxia. Neutrophils were incubated with GMCSF (50 U/ml) for 20 
h in atmospheres containing 21%, 2.5% or 0% O: (closed bars). The 
control cells were incubated under the same conditions but in the 
absence of cytokine (open bars). The data are expressed as the 
mean + S.E.M. ofn = 5 separate experiments each performed in tripli- 
cate. Under each 02 condition tested, the addition of GM-CSF caused 
a significant inhibition of apoptosis (P < 0.05), 
ous a study which demonstrated that SOD was ineffective in 
preventing cell death in human lung fetal fibroblasts [33]. In 
contrast, catalase, both alone, and in combination with SOD, 
caused a significant inhibition of neutrophil apoptosis (Fig. 3). 
It is probable, however, that this effect of catalase is independ- 
ent of its effects on hydrogen peroxide levels since a similar 
anti-apoptotic effect of catalase has been demonstrated in
WEHI 231 cells [34] and catalase has now been identified as the 
anti-apoptotic factor present in the conditioned medium of 
CCRF-CEM T-cell leukaemia cells [35]. This conclusion is sup- 
ported by the lack of effect of SOD and Trolox. Of interest, we 
also observed that the endogenous SOD and catalase levels in 
neutrophils measured by standard methods [36,37], was signif- 
icantly increased under hypoxic culture conditions (SOD activ- 
ity after 20 h culture in 21% 02 was 10.05 + 0.287 U/mg protein 
and in 0% O2 was 18.68 + 3.32 U/mg protein (P < 0.05). Cata- 
lase activity after 20 h culture in 21% 02 was 125 + 13.83 U/rag 
protein and in 0% 02 was 263 + 32.71 U/protein (P < 0.05)). It 
is likely that this induction of antioxidant enzymes represents 
a stress response to the hypoxia since Das et al. have shown that 
Mn SOD and catalase are two of a number of stress-related 
genes up-regulated in cardiac biopsy tissue following repeated 
ischaemia [38]. Whether the anti-apoptotic effect of hypoxia 
relates to the induction of other stress-related proteins or 
changes in poly-ADP-ribose transferase activity and hence 
ATP levels [39,40], lipid oxidation [41], regulation of NF~B 
activation [42], or some alternative mechanism, requires further 
investigation. 
Having shown that neutrophil survival in vitro can be pro- 
longed by hypoxia where the cells' capacity to generate ROS, 
at least in 0% 02, is severely diminished [18] we investigated the 
direct effect of ROS on the rate of neutrophil apoptosis. Hydro- 
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gen peroxide (0.1-5 mM) induced a concentration-dependent 
increase in the rate ofapoptosis observed at 8 hrs (Fig. 4a). Cell 
viability as judged by Trypan-blue dye exclusion was not af- 
fected by hydrogen peroxide treatments below 5 mM (half-life 
of the hydrogen peroxide in this system was 2.25 h as deter- 
mined by the reduction of absorbance at 240 nm). In view of 
the potent antioxidant capacity of serum (in our donors equiv- 
alent o a Trolox concentration f 1.08 1.12 mM [43], data not 
shown), the serum concentration in the Iscove's DMEM these 
experiments was reduced from 10% to 2%. The ability of 1 mM 
hydrogen peroxide to increase the number of cells undergoing 
apoptosis could be reversed by the addition of the antioxidant 
Trolox (10 mM), a soluble vitamin E analogue (Fig. 4b). This 
suggests that a potential pathway exists for oxidants to induce 
neutrophil apoptosis. However, it is important to note that 
activation of the respiratory burst by agents uch as fMLP and 
IL-8 does not increase the rate of neutrophil apoptosis [13]. 
This, together with the observation that only an extremely high, 
supraphysiological concentration of hydrogen peroxide in- 
creases neutrophil apoptosis, and the inability of SOD, 
methionine and Trolox to mimic the effect of withdrawal of 
oxygen (Fig. 4b), implies that generation of superoxide anion, 
hypochlorous and peroxyl radicals may not be a major regula- 
tor of neutrophil apoptosis in vivo. 
In conclusion, hypoxia caused a profound inhibition of neu- 
trophil apoptosis in vitro. This effect is directly opposite to the 
pro-apoptotic effect of hypoxia observed in a number of cell- 
lines [20-21,28-30]. The ability of hypoxia to prolong neutro- 
phil survival is additive to that induced by GM-CSF, is not 
associated with bcl-2 expression, and is not mimicked by ex- 
ogenous SOD, methionine or Trolox. However, apoptosis was 
inhibited by catalase, but the exact mechanism underlying this 
effect and the potential role of hydroxyl radicals and hydro- 
gen peroxide require further investigation. These data also im- 
ply that examination of apoptosis under routine hyperoxic 
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Fig. 3. Effect of SOD, catalase and methionine on neutrophil apoptosis. 
Neutrophils were cultured for 6 h (open bars) or 20 h (closed bars) 
in the presence of200 ,ug/ml SOD, 250 pg/ml catalase, 200/zg/ml SOD 
and 250,ug/ml catalase, or 5 mM methionine. Control, untreated neu- 
trophils were also prepared. Apoptosis was assessed morphologically. 
Data represent mean _+ S.E.M. of n = 3 separate xperiments, each 
performed in triplicate. 
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Fig. 4. Effects of hydrogen peroxide and Trolox on neutrophil apopto- 
sis. Neutrophils were incubated for 8 h in the presence or absence of 
(a) increasing concentrations of hydrogen peroxide or (b) 10 mM 
Trolox + 1 mM hydrogen peroxide. Apoptosis was assessed morpho- 
logically. Both sets of data represent mean + S.E.M. ofn = 3 separate 
experiments, each performed intriplicate. The rate of neutrophil apop- 
tosis in response to 1, 2 and 5 mM hydrogen peroxide was significantly 
different from the control apoptosis (*P < 0.05). In (b) the rate of 
apoptosis when cells were treated with both Trolox and hydrogen 
peroxide was significantly less than the rate of apoptosis when treated 
with hydrogen peroxide alone (*P < 0.005); there was no significant 
difference between the rates of apoptosis of the control cells, Trolox 
treated cells and Trolox and hydrogen peroxide treated cells. 
(21% 02) culture conditions may alter the susceptibility ofcells 
to apoptosis and not accurately reflect the 02 environment in 
vivo. In addition, neutrophils may remain alive and viable for 
considerably longer periods when recruited to an inflammatory 
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locus where there is local, and often systemic, hypoxia [23,24]. 
The effect on neutrophil survival, and hence delay in their 
removal, could potentially exacerbate the disease state and re- 
sult in additional neutrophil-mediated issue destruction. This 
linding may also have the practical consequence of stimulating 
~ esearch into the role ofhypoxic onditions for prolonged gran- 
~locyte storage prior to transfusion. 
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